Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Human Papillomavirus Types
100%
Neutralizing Monoclonal Antibody
100%
Virus-like
37%
Surface Loops
37%
Neutralizing Antibodies
25%
Papillomavirus Infections
25%
Pentamer
25%
Loop Structure
25%
Vaccination
12%
Epitope
12%
Type-specific
12%
Cross-reactivity
12%
HPV16
12%
HPV11
12%
HPV18
12%
Cervical Cancer
12%
Etiological Agents
12%
Protection Mechanism
12%
Antibody Binding
12%
Conformational Differences
12%
Immunology and Microbiology
Crystal Structure
100%
Capsid
100%
Monoclonal Antibody
100%
Wart Virus
100%
Surface Property
25%
Virus-Like Particle
25%
Neutralizing Antibody
16%
Epitope
8%
Monospecific Antibody
8%
Vaccine Efficacy
8%
Vaccination Policy
8%
Human Papillomavirus Type 16
8%
Human Papillomavirus Type 18
8%
Human Papillomavirus Type 11
8%
Cross-Reactivity
8%
Binding Antibody
8%
Human Papillomavirus Type 35
8%